 Background. Anecdotal reports and uncontrolled studies have described an association between generic substitution of antiepileptic drugs AEDs and adverse events, including loss of seizure control. Although these results are likely to be influenced by methodological bias, they have led to a strong opposition, among physicians and patients, to the use of generic products in epilepsy. 